These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25909201)

  • 41. Obesity and cardiovascular risk: the new public health problem of worldwide proportions.
    Scaglione R; Argano C; Di Chiara T; Licata G
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):203-12. PubMed ID: 15151469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pathophysiology of hypertension : What are our current concepts?].
    Jordan J
    Internist (Berl); 2015 Mar; 56(3):219-23. PubMed ID: 25668442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natriuretic peptides and the dialysis patient.
    Suresh M; Farrington K
    Semin Dial; 2005; 18(5):409-19. PubMed ID: 16191182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The natriuretic peptides.
    Baxter GF
    Basic Res Cardiol; 2004 Mar; 99(2):71-5. PubMed ID: 14963664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac hormones as diagnostic tools in heart failure.
    Ruskoaho H
    Endocr Rev; 2003 Jun; 24(3):341-56. PubMed ID: 12788803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paradoxical clearance of natriuretic peptide between pulmonary and systemic circulation: a pulmonary mechanism of maintaining natriuretic peptide plasma concentration in obese individuals.
    Date T; Yamane T; Yamashita S; Matsuo S; Matsushima M; Inada K; Taniguchi I; Yoshimura M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E14-21. PubMed ID: 22049176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions.
    Schlaich MP; Grassi G; Lambert GW; Straznicky N; Esler MD; Dixon J; Lambert EA; Redon J; Narkiewicz K; Jordan J; ;
    J Hypertens; 2009 Feb; 27(2):207-11. PubMed ID: 19155773
    [No Abstract]   [Full Text] [Related]  

  • 48. Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor.
    Johns DG; Ao Z; Heidrich BJ; Hunsberger GE; Graham T; Payne L; Elshourbagy N; Lu Q; Aiyar N; Douglas SA
    Biochem Biophys Res Commun; 2007 Jun; 358(1):145-9. PubMed ID: 17475216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical utility of natriuretic peptides in dialysis patients.
    Wang AY
    Semin Dial; 2012 May; 25(3):326-33. PubMed ID: 22607214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Obesity as pathology of adipocytes: number of cells, volume of arterial bloodstream,local pools of circulation in vivo, natriuretic peptides and arterial hypertension].
    Titov VN; Dmitriev VA
    Klin Lab Diagn; 2015 Mar; 60(3):4-13. PubMed ID: 26031157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natriuretic peptides: ready for prime-time in hypertension?
    Bricca G; Lantelme P
    Arch Cardiovasc Dis; 2011; 104(6-7):403-9. PubMed ID: 21798473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Moderate renal failure: a significant cardiovascular risk factor].
    Dulau-Florea I; Franke J; Mann J
    Dtsch Med Wochenschr; 2003 May; 128(22):1247-51. PubMed ID: 12772084
    [No Abstract]   [Full Text] [Related]  

  • 54. [Endothelial dysfunction in hypertension. The role of natriuretic peptides and endothelin].
    Irzmański R; Serwa-Stepień E; Barylski M; Banach M; Kowalski J; Pawlicki L
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S457-61. PubMed ID: 20527401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypertension and obesity after the menopause.
    Rappelli A
    J Hypertens Suppl; 2002 May; 20(2):S26-8. PubMed ID: 12183846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natriuretic peptides as diagnostic test: lessons from the first 5 years of clinical application.
    Daniels LB; Maisel AS
    Heart Fail Clin; 2006 Jul; 2(3):299-309. PubMed ID: 17386899
    [No Abstract]   [Full Text] [Related]  

  • 57. The clinical consequences of obstructive sleep apnea and associated excessive sleepiness.
    Hirshkowitz M
    J Fam Pract; 2008 Aug; 57(8 Suppl):S9-16. PubMed ID: 18687238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current role of neprilysin inhibitors in hypertension and heart failure.
    von Lueder TG; Atar D; Krum H
    Pharmacol Ther; 2014 Oct; 144(1):41-9. PubMed ID: 24836726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thyroid replacement therapy and heart failure.
    Gerdes AM; Iervasi G
    Circulation; 2010 Jul; 122(4):385-93. PubMed ID: 20660814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.